Announcement on Convening the Q3 2025 Performance Briefing
Filed with SSE · · 2 pages · Chinese
Shanghai Haohai Biological Technology Co., Ltd. on 6ix
Earlier from Shanghai Haohai Biological Technology
- Announcement on Using Temporarily Idle Raised Funds for Cash Management
- Report for Q3 2025
- Announcement on Implementation of Semi-annual Dividend Distribution for 2025
- Announcement on Receipt of the Prior Notice of Administrative Penalty by One of the Company’s Controlling Shareholders and Actual Controllers Due to Non-company-related Matters
- Announcement on Attending Semi-annual Collective Performance Briefing for Enterprises in Biological Products and CXO Industries on SSE STAR Market 2025
Later from Shanghai Haohai Biological Technology
- Announcement on Opening Special Settlement Account for Cash Management Products of Raised Funds
- Announcement on Canceling SomeRestricted Stock Granted but Not Yet Vested in 2021 A-share Restricted Stock Incentive Plan
- Indicative Announcement on Cancellation of Repurchased H-shares and the Passive Equity Change of Controlling Shareholder, Actual Controller and Its Persons Acting in Concert Reaching 1% Scale
- Announcement on Shareholding Reduction Plan for Shareholders
- Announcement on Preliminary Earnings Estimate for 2025
Follow Shanghai Haohai Biological Technology into a list and get an email when it puts out news.
Follow Shanghai Haohai Biological Technology